Neogenomics (NEO) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Neogenomics (NEO) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -7.69% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.22% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | 27.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.89% |
| Mar 31, 2026 | 17.80% |
| Dec 31, 2025 | 24.20% |
| Sep 30, 2025 | 9.71% |
| Jun 30, 2025 | -8.50% |
| Mar 31, 2025 | 19.35% |
| Dec 31, 2024 | 28.41% |
| Sep 30, 2024 | 4.54% |
| Jun 30, 2024 | -30.95% |
| Mar 31, 2024 | -6.96% |
| Dec 31, 2023 | -43.08% |
| Sep 30, 2023 | -109.85% |
| Jun 30, 2023 | -52.77% |
| Mar 31, 2023 | -64.03% |
| Dec 31, 2022 | -77.62% |
| Sep 30, 2022 | -167.76% |
| Jun 30, 2022 | -170.22% |
| Mar 31, 2022 | -173.16% |
| Dec 31, 2021 | -393.65% |
| Sep 30, 2021 | -129.31% |